Risk factor
Poor trading liquidity
Profitability factor
Greatly overvalued vs peers
About
Yomeishu Seizo Co., Ltd. produces and sells herbal liqueurs and pharmaceutical products in Japan, Hong Kong, Malaysia, Singapore, and Taiwan. It offers Yomeishu, an herbal liqueur; ginger, ginseng, honey, and medicinal liqueur; fruit and herbs liqueur; Kanomori and Kanoshizuku gin; and craft gin cocktail products. The company also provides Yomeishu cough drops; Yomeishu Seizo Amazake; Herb-no-Megumi; Ururu vinegar drinks; ginger black vinegar drinks; and dilution type black vinegar drinks. In addition, it offers Koken Seisai designated quasi-pharmaceutical and health products through the mail order site www.yomeishu-online.jp. Further, the company operates CLASUWA, a commercial complex; rents/leases real estate properties; manages restaurants and shops; and generates, supplies, and sells electricity through natural energy. Yomeishu Seizo Co., Ltd. was incorporated in 1923 and is headquartered in Tokyo, Japan.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITD.
